5-(tetradecyloxy)-2-furancarboxylic acid has been researched along with Kahler Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Medina, EA; Oberheu, K; Ortega, V; Oyajobi, BO; Polusani, SR; Velagaleti, GV | 1 |
1 other study(ies) available for 5-(tetradecyloxy)-2-furancarboxylic acid and Kahler Disease
Article | Year |
---|---|
PKA/AMPK signaling in relation to adiponectin's antiproliferative effect on multiple myeloma cells.
Topics: Acetyl-CoA Carboxylase; Adipokines; Adiponectin; AMP-Activated Protein Kinases; Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclic AMP-Dependent Protein Kinases; Disease Progression; Fatty Acids; Furans; Humans; Lipogenesis; Metabolism, Inborn Errors; Mice; Multiple Myeloma; Obesity; Signal Transduction | 2014 |